Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

PFE – Pfizer Inc.

Float Short %

1.9

Margin Of Safety %

26

Put/Call OI Ratio

0.83

EPS Next Q Diff

-0.08

EPS Last/This Y

-0.04

EPS This/Next Y

0.07

Price

25.87

Target Price

28.5

Analyst Recom

2.46

Performance Q

12.33

Relative Volume

0.83

Beta

0.5

Ticker: PFE




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-07-25PFE24.781.010.392778684
2025-07-28PFE24.320.960.612686819
2025-07-29PFE24.30.950.512718681
2025-07-30PFE23.870.950.462739678
2025-07-31PFE23.290.950.522766167
2025-08-01PFE23.480.950.632801267
2025-08-04PFE23.510.930.702734611
2025-08-05PFE24.720.900.372869687
2025-08-06PFE23.940.900.372915298
2025-08-07PFE24.250.890.562950915
2025-08-08PFE24.580.880.272963759
2025-08-11PFE24.610.880.432823358
2025-08-12PFE24.60.880.452844420
2025-08-13PFE25.150.880.332856880
2025-08-14PFE25.080.870.232884341
2025-08-15PFE25.160.870.342890942
2025-08-18PFE25.110.860.392505724
2025-08-19PFE25.320.850.182542399
2025-08-20PFE25.370.830.452576879
2025-08-21PFE25.720.840.282604224
2025-08-22PFE25.860.830.232623624
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-07-25PFE24.79-4.611102.93.00
2025-07-28PFE24.33-4.411159.13.01
2025-07-29PFE24.30-4.411182.23.01
2025-07-30PFE23.81-4.410859.73.01
2025-07-31PFE23.29-4.410833.93.01
2025-08-01PFE23.49-4.411327.93.01
2025-08-04PFE23.53-4.411216.43.01
2025-08-05PFE24.75-4.412028.73.01
2025-08-06PFE23.93-4.410232.53.01
2025-08-07PFE24.23-4.48587.03.01
2025-08-08PFE24.58-28.88343.03.05
2025-08-11PFE24.61-28.88132.23.05
2025-08-12PFE24.64-28.88151.83.05
2025-08-13PFE25.16-28.88444.13.05
2025-08-14PFE25.10-28.88077.43.05
2025-08-15PFE25.16-30.88144.83.06
2025-08-18PFE25.05-30.88054.93.06
2025-08-19PFE25.32-30.58273.03.06
2025-08-20PFE25.38-30.58147.83.06
2025-08-21PFE25.72-32.68329.03.07
2025-08-22PFE25.87-32.68194.63.07
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-07-25PFE0.180.591.75
2025-07-28PFE0.182.991.75
2025-07-29PFE0.182.991.75
2025-07-30PFE0.182.991.75
2025-07-31PFE0.182.991.75
2025-08-01PFE0.182.991.75
2025-08-04PFE0.182.561.75
2025-08-05PFE0.182.561.75
2025-08-06PFE0.182.561.75
2025-08-07PFE0.182.561.75
2025-08-08PFE0.182.561.75
2025-08-11PFE0.182.651.75
2025-08-12PFE0.182.651.90
2025-08-13PFE0.182.651.90
2025-08-14PFE0.182.651.90
2025-08-15PFE-0.032.651.90
2025-08-18PFE-0.032.251.90
2025-08-19PFE-0.042.251.90
2025-08-20PFE-0.042.251.90
2025-08-21PFE-0.042.251.90
2025-08-22PFE-0.042.251.90
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

0.78

Avg. EPS Est. Current Quarter

0.71

Avg. EPS Est. Next Quarter

0.7

Insider Transactions

-0.04

Institutional Transactions

2.25

Beta

0.5

Average Sales Estimate Current Quarter

17102

Average Sales Estimate Next Quarter

17725

Fair Value

32.65

Quality Score

87

Growth Score

58

Sentiment Score

71

Actual DrawDown %

58.1

Max Drawdown 5-Year %

-59

Target Price

28.5

P/E

13.76

Forward P/E

8.24

PEG

P/S

2.31

P/B

1.66

P/Free Cash Flow

11.83

EPS

1.88

Average EPS Est. Cur. Y​

3.07

EPS Next Y. (Est.)

3.14

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

16.81

Relative Volume

0.83

Return on Equity vs Sector %

-12.6

Return on Equity vs Industry %

-20.9

EPS 1 7Days Diff

EPS 1 30Days Diff

0.07

EBIT Estimation

8194.6
Pfizer, Inc.
Sector: Healthcare
Industry: Drug Manufacturers - General
Employees: 81000
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, Octagam, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
stock quote shares PFE – Pfizer Inc. Stock Price stock today
news today PFE – Pfizer Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch PFE – Pfizer Inc. yahoo finance google finance
stock history PFE – Pfizer Inc. invest stock market
stock prices PFE premarket after hours
ticker PFE fair value insiders trading